Reema Kashif

Reema Kashif, MD

Clinical Assistant Professor, Director Of Sickle Cell Disease Clinic

Business Phone: (352) 273-9011
Business Email:

About Reema Kashif

Doctor Reema Kashif grew up as a first generation Egyptian-Iraqi in Charlotte, North Carolina. She went on to graduate Cum Laude at the College of Charleston in South Carolina as a Biology major and a Spanish minor. After she graduated from college, she lived abroad in London, United Kingdom for one year as a research assistant to an orthopedic surgeon. She went on to gain clinical experience as a surgical assistant to a Mohs surgeon in Washington, D.C for another year before starting medical school. She obtained her medical doctorate at the University of South Carolina, which is where she decided she wanted to become a pediatrician like her mother. During her residency at Miami Children’s Hospital, she found her love of working along side families of children with blood disorders and malignancies . She is excited for what the future holds as she pursues her fellowship in pediatric hematology-oncology at the University of Florida (UF). Despite her desire of pursuing a well rounded training in both hematology and oncology specialties at UF, her main interest is benign hematology and she plans on specializing in Sickle Cell Disease after she graduates from her fellowship in the year 2023.

Additional Positions:
Emergency Medicine Technician
2013 – 2015 · Greenville County Emergency Medical Services
Surgical Technician/Medical Assistant
2012 – 2013 · Dermassociates
Research Assistant
2011 – 2012 · Epsom and St. Helier NHS Hospital


Fellow Award for 10,000 Dollars
2022 · Children’s Miracle Network

Board Certifications

  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Areas of Interest
  • Sickle cell disease
  • Transition from Pediatric to Adult Care

Research Profile

Doctor Reema Kashif had previously involved herself with Doctor Arun Srivastava’s Laboratory during her Pediatric Hematology Oncology fellowship, coordinating research projects in anticipation of the ever expanding developments of gene therapies for hematologic diseases. Her proposed research aim was optimizing adenoassociated virus mediated in vivo delivery of therapeutic genes to human hematopoetic stem cells as a promising alternative to allogeneic transplantation to potentially cure hemoglobinapathies such as Sickle Cell Disease and Beta Thalassemia.

Open Researcher and Contributor ID (ORCID)



Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan.
Pediatric Blood and Cancer. [DOI] 10.1002/pbc.30958.
Cerebral Fat Embolism in Pediatric Sickle Cell Disease
Critical Care Medicine. 51(1):321-321 [DOI] 10.1097/01.ccm.0000908384.59494.21.
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study.
JCO precision oncology. 7 [DOI] 10.1200/PO.22.00580. [PMID] 36952646.
Trauma-Derived Rotational Vertebral Artery Syndrome in an Eight Year Old Boy
Critical Care Medicine. 51(1):656-656 [DOI] 10.1097/01.ccm.0000910988.25012.cb.
Enhanced Transduction Efficiency of AAV Vectors Mediated by Polyvinyl Alcohol and Human Serum Albumin is Serotype- and Cell-Type Specific
American Society of Gene & Cell Therapy. W-33(907)
No Specific Factors Associated with Risk of Readmission for Rebound Pain in Children with Sickle Cell Disease and Asthma Treated with Systemic Corticosteroids
Blood. 140(Supplement 1):8290-8291 [DOI] 10.1182/blood-2022-167093.
Malignant Transformation of Paravertebral Mass from Ganglioneuroblastoma to Neuroblastoma
Pediatric Blood & Cancer. . 68(S3) [DOI]  10.1002/pbc.29060.
Pharmacogenomic Single Nucleotide Polymorphism (SNP) Variants As Predictors of Toxicity Phenotypes in the Treatment of Acute Childhood Leukemia
Blood. 138(Supplement 1):3360-3360 [DOI] 10.1182/blood-2021-151357.
Platelet Microparticles as a Potential Cause of Cerebral Infarcts in a Pediatric Patient with ITP
Pediatric Blood & Cancer. 68(S3) [DOI] 10.1002/pbc.29060.
Profiling Cycling Trauma throughout the Body with and Without Helmet Usage in a Large United States Health-care Network.
Journal of emergencies, trauma, and shock. 13(1):73-77 [DOI] 10.4103/JETS.JETS_65_18. [PMID] 32395055.
Clinical Description And Medical Management Of Necrotizing Lymphadenitis In A Sickle Cell Child
Pediatric Blood and Cancer. 66(S2) [DOI] 10.1002/pbc.27341.
Demographic variation in the injury patterns of adult cyclists admitted to a large US healthcare network: A five-year review
Trauma. 21(3):184-191 [DOI] 10.1177/1460408617740903.
Metastatic high grade neuroepithelial tumor in a child with PLAG1 amplification
Nicklaus Children's Hospital : Milestones in Medical Education . 9(4):51-RES-030-CR
Pineal Germ Cell Tumor presenting with Intracranial Bleeding after Endoscopic Third Ventriculostomy
Pediatric Blood and Cancer. 66(S2) [DOI] 10.1002/pbc.e27713.
Primary Myelofibrosis With AML Transformation In A Child: Rare Presentation And Poor Therapy Response
Pediatric Blood & Cancer. 66(S2) [DOI] 10.1002/pbc.27713.
Sinusoidal Obstruction Syndrome On Head Start IV Regimen In Young Children With Embryonal Tumors
Pediatric Blood and Cancer. 66(S2) [DOI]


Pediatric Hematology Oncology Fellowship
2020-2023 · University of Florida
Pediatric Residency
2017-2020 · Nicklaus Children’s Hospital
Medical Degree
2013-2017 · University of South Carolina
Bachelor of Science
2007-2011 · College of Charleston

Contact Details

(352) 273-9011
Business Mailing:
PO Box 100296